Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma

• Anne-Sophie Michallet,
• Yann Guillermin,
• Benedicte Deau,
• Laure Lebras,
• Stephanie Harel,
• Sandy Amorin,
• Claire Reynes,
• Gilles Salles,
• Fabien Subtil,
• Pauline Brice

Affiliations

Anne-Sophie Michallet

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France

Yann Guillermin

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France

Benedicte Deau

Centre Hospitalier Cochin, Department of Hematology, Paris, France

Laure Lebras

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France

Stephanie Harel

Centre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France

Sandy Amorin

Centre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France

Claire Reynes

Centre Hospitalier Annecy, Department of Hematology, Pierre Bénite, France

Gilles Salles

Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Hematology, Pierre Bénite, France;Université de Lyon, Faculté de Médecine Lyon-Sud Charles Mérieux, Pierre Bénite, France

Fabien Subtil

Hospices Civils de Lyon, Service de Biostatistique, CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Lyon, France

Pauline Brice

Centre Hospitalier Saint-Louis, Lymphoid Malignancies Unit, Paris, France